Vassilios Myrianthopoulos

8PUBLICATIONS
25CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and designBiologically active moleculesMetal cluster chemistryCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 28, 2026
Sodium Channel Blockers Demonstrate Binding Affinity for the Tandem Tudor Domain of the Epigenetic Hub UHRF1.

|Aug 26, 2026
Investigating the Binding Mode of a Naphthol-Based Inhibitor Targeting SARS-CoV-2 Main Protease.

|Aug 19, 2025
Discovery and Characterization of Uracil Derivatives Targeting the Set-and-Ring Domain of UHRF1.

Ifigeneia Akrani, Danai Driva, Efstratios Tsakalidis

|Oct 26, 2024
Discovery of Novel Inhibitors against ALS-Related SOD1(A4V) Aggregation through the Screening of a Chemical Library Using Differential Scanning Fluorimetry (DSF).

Maria Giannakou, Ifigeneia Akrani, Angeliki Tsoka

|Aug 29, 2024
Novel Pyrazino[1,2-a]indole-1,3(2H,4H)-dione Derivatives Targeting the Replication of Flaviviridae Viruses: Structural and Mechanistic Insights.

Erofili Giannakopoulou, Ifigeneia Akrani, George Mpekoulis

|Apr 30, 2021
Cockayne Syndrome Group B (CSB): The Regulatory Framework Governing the Multifunctional Protein and Its Plausible Role in Cancer.

Zoi Spyropoulou, Angelos Papaspyropoulos, Nefeli Lagopati

Pageof 2

Frequent Collaborators

5 joint publications

Emmanuel Mikros

2 joint publications

Ifigeneia Akrani

2 joint publications

Evangelos Gikas

2 joint publications

Efstratios Tsakalidis